In addition, oral semaglutide helps control other CV risk factors, such as blood pressure and lipid levels, potentially reducing the risk of future CV events [Table 2]
Neither the continued medication group nor the hold medication group experienced clinically significant RGV in the endoscopy with colonoscopy subgroup
Starting Resistance Training A practical starting point for building strength and preserving muscle
In the Retatrutide diabetes trial, gastrointestinal adverse events appeared in roughly 35 percent of treated participants, the same family of effects seen across this drug class, and no severe low-blood-sugar episodes or deaths were reported
Supplement companies are not required to disclose whether subjects in their marketing materials also changed their diet, exercise, or medications
Results from the current post hoc analysis are supported by earlier finding in individuals with obesity and prediabetes [10, 26]